Acute myeloid leukemia: open trials in Switzerland

9 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT07223814
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
CH-Basel-USB, Basel · CH-Bern-INSEL, Bern · CH-Fribourg-HFR, Fribourg · CH-Geneve (14)-HCUGE, Geneva · CH-St. Gallen-KSSG, Sankt Gallen · CH-Zürich-USZ, Zurich
Registry updated 2026-11-06
NCT05429632
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Trial Treatment · Phase 3 · Priothera SAS
Universitaetsspital Basel, Basel
Registry updated 2026-10-30
NCT07826897
Real-Time Breath Analysis in Acute Myeloid Leukaemia for a Rapid Characterisation of Biological Subtypes and to Predict Therapy Responses
Research · Jeremy Deuel
University Hospital of Zurich, Zurich
Registry updated 2026-09-17
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
Universitätsspital Basel, Basel
Registry updated 2026-09-15
NCT06652438
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
CH-Aarau-KSA, Aarau · CH-Basel-USB, Basel · CH-Bellinzona-IOSI, Bellinzona · CH-Bern-INSEL, Bern · CH-Geneve (14)-HCUGE, Geneva · CH-Zürich-USZ, Zurich
Registry updated 2026-09-02
NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.
University Hospital Basel, Basel · University Hospital Bern / Inselspital, Bern · Universitaetsspital Zuerich - Haematology, Zurich
Registry updated 2026-03-24
NCT03828773
PTX3-targeted Antifungal Prophylaxis
Trial Treatment · Phase 4 · Bochud Pierre-Yves
Cantonal Hospital Aarau, Aarau · University Hospital Basel, Basel · Cantonal Hospital HFR, Fribourg · University Hospital of Geneva (HUG), Geneva · University Hospital of Lausanne / Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Registry updated 2025-12-09
NCT03300492
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
Trial Treatment · Phase 1/2 · University Hospital, Basel, Switzerland
University Hospital Basel, Basel
Registry updated 2025-12-04
NCT07075016
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Trial Treatment · Phase 3 · Stichting Hemato-Oncologie voor Volwassenen Nederland
CH-Basel-USB, Basel · CH-Bellinzona-IOSI, Bellinzona · CH-Bern-INSEL, Bern · CH-Zürich-USZ, Zurich
Registry updated 2025-08-19

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error